Pediatrics Medicine Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatrics Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Tablets
1.2.3 Caplets
1.2.4 Oral Liquid
1.2.5 Capsules
1.2.6 Other
1.3 Market by Application
1.3.1 Global Pediatrics Medicine Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 Respiratory diseases
1.3.3 Infectious diseases
1.3.4 Gastrointestinal diseases
1.3.5 CNS diseases
1.3.6 Oncological diseases
1.3.7 CVDs
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pediatrics Medicine Market Perspective (2018-2029)
2.2 Pediatrics Medicine Growth Trends by Region
2.2.1 Pediatrics Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pediatrics Medicine Historic Market Size by Region (2018-2023)
2.2.3 Pediatrics Medicine Forecasted Market Size by Region (2024-2029)
2.3 Pediatrics Medicine Market Dynamics
2.3.1 Pediatrics Medicine Industry Trends
2.3.2 Pediatrics Medicine Market Drivers
2.3.3 Pediatrics Medicine Market Challenges
2.3.4 Pediatrics Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatrics Medicine Players by Revenue
3.1.1 Global Top Pediatrics Medicine Players by Revenue (2018-2023)
3.1.2 Global Pediatrics Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Pediatrics Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pediatrics Medicine Revenue
3.4 Global Pediatrics Medicine Market Concentration Ratio
3.4.1 Global Pediatrics Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatrics Medicine Revenue in 2022
3.5 Pediatrics Medicine Key Players Head office and Area Served
3.6 Key Players Pediatrics Medicine Product Solution and Service
3.7 Date of Enter into Pediatrics Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatrics Medicine Breakdown Data by Type
4.1 Global Pediatrics Medicine Historic Market Size by Type (2018-2023)
4.2 Global Pediatrics Medicine Forecasted Market Size by Type (2024-2029)
5 Pediatrics Medicine Breakdown Data by Application
5.1 Global Pediatrics Medicine Historic Market Size by Application (2018-2023)
5.2 Global Pediatrics Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Pediatrics Medicine Market Size (2018-2029)
6.2 North America Pediatrics Medicine Market Size by Country (2018-2023)
6.3 North America Pediatrics Medicine Market Size by Country (2024-2029)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Pediatrics Medicine Market Size (2018-2029)
7.2 Europe Pediatrics Medicine Market Size by Country (2018-2023)
7.3 Europe Pediatrics Medicine Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatrics Medicine Market Size (2018-2029)
8.2 Asia-Pacific Pediatrics Medicine Market Size by Country (2018-2023)
8.3 Asia-Pacific Pediatrics Medicine Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Pediatrics Medicine Market Size (2018-2029)
9.2 Latin America Pediatrics Medicine Market Size by Country (2018-2023)
9.3 Latin America Pediatrics Medicine Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatrics Medicine Market Size (2018-2029)
10.2 Middle East & Africa Pediatrics Medicine Market Size by Country (2018-2023)
10.3 Middle East & Africa Pediatrics Medicine Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Pediatrics Medicine Introduction
11.1.4 GSK Revenue in Pediatrics Medicine Business (2018-2023)
11.1.5 GSK Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Pediatrics Medicine Introduction
11.2.4 Novartis Revenue in Pediatrics Medicine Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Pediatrics Medicine Introduction
11.3.4 Pfizer Revenue in Pediatrics Medicine Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Pediatrics Medicine Introduction
11.4.4 Sanofi Revenue in Pediatrics Medicine Business (2018-2023)
11.4.5 Sanofi Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Pediatrics Medicine Introduction
11.5.4 Abbott Revenue in Pediatrics Medicine Business (2018-2023)
11.5.5 Abbott Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Detail
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Pediatrics Medicine Introduction
11.6.4 Bristol-Myers Squibb Revenue in Pediatrics Medicine Business (2018-2023)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Cipla
11.7.1 Cipla Company Detail
11.7.2 Cipla Business Overview
11.7.3 Cipla Pediatrics Medicine Introduction
11.7.4 Cipla Revenue in Pediatrics Medicine Business (2018-2023)
11.7.5 Cipla Recent Development
11.8 Eisai Pharmaceuticals
11.8.1 Eisai Pharmaceuticals Company Detail
11.8.2 Eisai Pharmaceuticals Business Overview
11.8.3 Eisai Pharmaceuticals Pediatrics Medicine Introduction
11.8.4 Eisai Pharmaceuticals Revenue in Pediatrics Medicine Business (2018-2023)
11.8.5 Eisai Pharmaceuticals Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Detail
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Pediatrics Medicine Introduction
11.9.4 Eli Lilly Revenue in Pediatrics Medicine Business (2018-2023)
11.9.5 Eli Lilly Recent Development
11.10 F. Hoffman-La Roche
11.10.1 F. Hoffman-La Roche Company Detail
11.10.2 F. Hoffman-La Roche Business Overview
11.10.3 F. Hoffman-La Roche Pediatrics Medicine Introduction
11.10.4 F. Hoffman-La Roche Revenue in Pediatrics Medicine Business (2018-2023)
11.10.5 F. Hoffman-La Roche Recent Development
11.11 Glenmark
11.11.1 Glenmark Company Detail
11.11.2 Glenmark Business Overview
11.11.3 Glenmark Pediatrics Medicine Introduction
11.11.4 Glenmark Revenue in Pediatrics Medicine Business (2018-2023)
11.11.5 Glenmark Recent Development
11.12 Helsinn Healthcare
11.12.1 Helsinn Healthcare Company Detail
11.12.2 Helsinn Healthcare Business Overview
11.12.3 Helsinn Healthcare Pediatrics Medicine Introduction
11.12.4 Helsinn Healthcare Revenue in Pediatrics Medicine Business (2018-2023)
11.12.5 Helsinn Healthcare Recent Development
11.13 Heron Therapeutics
11.13.1 Heron Therapeutics Company Detail
11.13.2 Heron Therapeutics Business Overview
11.13.3 Heron Therapeutics Pediatrics Medicine Introduction
11.13.4 Heron Therapeutics Revenue in Pediatrics Medicine Business (2018-2023)
11.13.5 Heron Therapeutics Recent Development
11.14 Ipca Laboratories
11.14.1 Ipca Laboratories Company Detail
11.14.2 Ipca Laboratories Business Overview
11.14.3 Ipca Laboratories Pediatrics Medicine Introduction
11.14.4 Ipca Laboratories Revenue in Pediatrics Medicine Business (2018-2023)
11.14.5 Ipca Laboratories Recent Development
11.15 Lupin Pharmaceuticals
11.15.1 Lupin Pharmaceuticals Company Detail
11.15.2 Lupin Pharmaceuticals Business Overview
11.15.3 Lupin Pharmaceuticals Pediatrics Medicine Introduction
11.15.4 Lupin Pharmaceuticals Revenue in Pediatrics Medicine Business (2018-2023)
11.15.5 Lupin Pharmaceuticals Recent Development
11.16 Merck Sharp & Dohme
11.16.1 Merck Sharp & Dohme Company Detail
11.16.2 Merck Sharp & Dohme Business Overview
11.16.3 Merck Sharp & Dohme Pediatrics Medicine Introduction
11.16.4 Merck Sharp & Dohme Revenue in Pediatrics Medicine Business (2018-2023)
11.16.5 Merck Sharp & Dohme Recent Development
11.17 RedHill
11.17.1 RedHill Company Detail
11.17.2 RedHill Business Overview
11.17.3 RedHill Pediatrics Medicine Introduction
11.17.4 RedHill Revenue in Pediatrics Medicine Business (2018-2023)
11.17.5 RedHill Recent Development
11.18 Sun Pharmaceutical Industries
11.18.1 Sun Pharmaceutical Industries Company Detail
11.18.2 Sun Pharmaceutical Industries Business Overview
11.18.3 Sun Pharmaceutical Industries Pediatrics Medicine Introduction
11.18.4 Sun Pharmaceutical Industries Revenue in Pediatrics Medicine Business (2018-2023)
11.18.5 Sun Pharmaceutical Industries Recent Development
11.19 Takeda Pharmaceutical
11.19.1 Takeda Pharmaceutical Company Detail
11.19.2 Takeda Pharmaceutical Business Overview
11.19.3 Takeda Pharmaceutical Pediatrics Medicine Introduction
11.19.4 Takeda Pharmaceutical Revenue in Pediatrics Medicine Business (2018-2023)
11.19.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Pediatrics Medicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Tablets
Table 3. Key Players of Caplets
Table 4. Key Players of Oral Liquid
Table 5. Key Players of Capsules
Table 6. Key Players of Other
Table 7. Global Pediatrics Medicine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Pediatrics Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Pediatrics Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Pediatrics Medicine Market Share by Region (2018-2023)
Table 11. Global Pediatrics Medicine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Pediatrics Medicine Market Share by Region (2024-2029)
Table 13. Pediatrics Medicine Market Trends
Table 14. Pediatrics Medicine Market Drivers
Table 15. Pediatrics Medicine Market Challenges
Table 16. Pediatrics Medicine Market Restraints
Table 17. Global Pediatrics Medicine Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Pediatrics Medicine Market Share by Players (2018-2023)
Table 19. Global Top Pediatrics Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatrics Medicine as of 2022)
Table 20. Ranking of Global Top Pediatrics Medicine Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Pediatrics Medicine Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pediatrics Medicine Product Solution and Service
Table 24. Date of Enter into Pediatrics Medicine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pediatrics Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Pediatrics Medicine Revenue Market Share by Type (2018-2023)
Table 28. Global Pediatrics Medicine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Pediatrics Medicine Revenue Market Share by Type (2024-2029)
Table 30. Global Pediatrics Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Pediatrics Medicine Revenue Market Share by Application (2018-2023)
Table 32. Global Pediatrics Medicine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Pediatrics Medicine Revenue Market Share by Application (2024-2029)
Table 34. North America Pediatrics Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Pediatrics Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Pediatrics Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Pediatrics Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Pediatrics Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Pediatrics Medicine Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Pediatrics Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Pediatrics Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Pediatrics Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 43. Middle East & Africa Pediatrics Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 44. GSK Company Detail
Table 45. GSK Business Overview
Table 46. GSK Pediatrics Medicine Product
Table 47. GSK Revenue in Pediatrics Medicine Business (2018-2023) & (US$ Million)
Table 48. GSK Recent Development
Table 49. Novartis Company Detail
Table 50. Novartis Business Overview
Table 51. Novartis Pediatrics Medicine Product
Table 52. Novartis Revenue in Pediatrics Medicine Business (2018-2023) & (US$ Million)
Table 53. Novartis Recent Development
Table 54. Pfizer Company Detail
Table 55. Pfizer Business Overview
Table 56. Pfizer Pediatrics Medicine Product
Table 57. Pfizer Revenue in Pediatrics Medicine Business (2018-2023) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. Sanofi Company Detail
Table 60. Sanofi Business Overview
Table 61. Sanofi Pediatrics Medicine Product
Table 62. Sanofi Revenue in Pediatrics Medicine Business (2018-2023) & (US$ Million)
Table 63. Sanofi Recent Development
Table 64. Abbott Company Detail
Table 65. Abbott Business Overview
Table 66. Abbott Pediatrics Medicine Product
Table 67. Abbott Revenue in Pediatrics Medicine Business (2018-2023) & (US$ Million)
Table 68. Abbott Recent Development
Table 69. Bristol-Myers Squibb Company Detail
Table 70. Bristol-Myers Squibb Business Overview
Table 71. Bristol-Myers Squibb Pediatrics Medicine Product
Table 72. Bristol-Myers Squibb Revenue in Pediatrics Medicine Business (2018-2023) & (US$ Million)
Table 73. Bristol-Myers Squibb Recent Development
Table 74. Cipla Company Detail
Table 75. Cipla Business Overview
Table 76. Cipla Pediatrics Medicine Product
Table 77. Cipla Revenue in Pediatrics Medicine Business (2018-2023) & (US$ Million)
Table 78. Cipla Recent Development
Table 79. Eisai Pharmaceuticals Company Detail
Table 80. Eisai Pharmaceuticals Business Overview
Table 81. Eisai Pharmaceuticals Pediatrics Medicine Product
Table 82. Eisai Pharmaceuticals Revenue in Pediatrics Medicine Business (2018-2023) & (US$ Million)
Table 83. Eisai Pharmaceuticals Recent Development
Table 84. Eli Lilly Company Detail
Table 85. Eli Lilly Business Overview
Table 86. Eli Lilly Pediatrics Medicine Product
Table 87. Eli Lilly Revenue in Pediatrics Medicine Business (2018-2023) & (US$ Million)
Table 88. Eli Lilly Recent Development
Table 89. F. Hoffman-La Roche Company Detail
Table 90. F. Hoffman-La Roche Business Overview
Table 91. F. Hoffman-La Roche Pediatrics Medicine Product
Table 92. F. Hoffman-La Roche Revenue in Pediatrics Medicine Business (2018-2023) & (US$ Million)
Table 93. F. Hoffman-La Roche Recent Development
Table 94. Glenmark Company Detail
Table 95. Glenmark Business Overview
Table 96. Glenmark Pediatrics MedicineProduct
Table 97. Glenmark Revenue in Pediatrics Medicine Business (2018-2023) & (US$ Million)
Table 98. Glenmark Recent Development
Table 99. Helsinn Healthcare Company Detail
Table 100. Helsinn Healthcare Business Overview
Table 101. Helsinn Healthcare Pediatrics MedicineProduct
Table 102. Helsinn Healthcare Revenue in Pediatrics Medicine Business (2018-2023) & (US$ Million)
Table 103. Helsinn Healthcare Recent Development
Table 104. Heron Therapeutics Company Detail
Table 105. Heron Therapeutics Business Overview
Table 106. Heron Therapeutics Pediatrics MedicineProduct
Table 107. Heron Therapeutics Revenue in Pediatrics Medicine Business (2018-2023) & (US$ Million)
Table 108. Heron Therapeutics Recent Development
Table 109. Ipca Laboratories Company Detail
Table 110. Ipca Laboratories Business Overview
Table 111. Ipca Laboratories Pediatrics MedicineProduct
Table 112. Ipca Laboratories Revenue in Pediatrics Medicine Business (2018-2023) & (US$ Million)
Table 113. Ipca Laboratories Recent Development
Table 114. Lupin Pharmaceuticals Company Detail
Table 115. Lupin Pharmaceuticals Business Overview
Table 116. Lupin Pharmaceuticals Pediatrics MedicineProduct
Table 117. Lupin Pharmaceuticals Revenue in Pediatrics Medicine Business (2018-2023) & (US$ Million)
Table 118. Lupin Pharmaceuticals Recent Development
Table 119. Merck Sharp & Dohme Company Detail
Table 120. Merck Sharp & Dohme Business Overview
Table 121. Merck Sharp & Dohme Pediatrics MedicineProduct
Table 122. Merck Sharp & Dohme Revenue in Pediatrics Medicine Business (2018-2023) & (US$ Million)
Table 123. Merck Sharp & Dohme Recent Development
Table 124. RedHill Company Detail
Table 125. RedHill Business Overview
Table 126. RedHill Pediatrics MedicineProduct
Table 127. RedHill Revenue in Pediatrics Medicine Business (2018-2023) & (US$ Million)
Table 128. RedHill Recent Development
Table 129. Sun Pharmaceutical Industries Company Detail
Table 130. Sun Pharmaceutical Industries Business Overview
Table 131. Sun Pharmaceutical Industries Pediatrics MedicineProduct
Table 132. Sun Pharmaceutical Industries Revenue in Pediatrics Medicine Business (2018-2023) & (US$ Million)
Table 133. Sun Pharmaceutical Industries Recent Development
Table 134. Takeda Pharmaceutical Company Detail
Table 135. Takeda Pharmaceutical Business Overview
Table 136. Takeda Pharmaceutical Pediatrics MedicineProduct
Table 137. Takeda Pharmaceutical Revenue in Pediatrics Medicine Business (2018-2023) & (US$ Million)
Table 138. Takeda Pharmaceutical Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatrics Medicine Market Share by Type: 2022 VS 2029
Figure 2. Tablets Features
Figure 3. Caplets Features
Figure 4. Oral Liquid Features
Figure 5. Capsules Features
Figure 6. Other Features
Figure 7. Global Pediatrics Medicine Market Share by Application in 2022 & 2029
Figure 8. Respiratory diseases Case Studies
Figure 9. Infectious diseases Case Studies
Figure 10. Gastrointestinal diseases Case Studies
Figure 11. CNS diseases Case Studies
Figure 12. Oncological diseases Case Studies
Figure 13. CVDs Case Studies
Figure 14. Others Case Studies
Figure 15. Pediatrics Medicine Report Years Considered
Figure 16. Global Pediatrics Medicine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Pediatrics Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Pediatrics Medicine Market Share by Region: 2022 VS 2029
Figure 19. Global Pediatrics Medicine Market Share by Players in 2022
Figure 20. Global Top Pediatrics Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatrics Medicine as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Pediatrics Medicine Revenue in 2022
Figure 22. North America Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. North America Pediatrics Medicine Market Share by Country (2018-2029)
Figure 24. United States Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Pediatrics Medicine Market Share by Country (2018-2029)
Figure 28. Germany Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Pediatrics Medicine Market Share by Region (2018-2029)
Figure 36. China Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Japan Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. South Korea Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. India Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Australia Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Pediatrics Medicine Market Share by Country (2018-2029)
Figure 44. Mexico Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Brazil Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Pediatrics Medicine Market Share by Country (2018-2029)
Figure 48. Turkey Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Pediatrics Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. GSK Revenue Growth Rate in Pediatrics Medicine Business (2018-2023)
Figure 51. Novartis Revenue Growth Rate in Pediatrics Medicine Business (2018-2023)
Figure 52. Pfizer Revenue Growth Rate in Pediatrics Medicine Business (2018-2023)
Figure 53. Sanofi Revenue Growth Rate in Pediatrics Medicine Business (2018-2023)
Figure 54. Abbott Revenue Growth Rate in Pediatrics Medicine Business (2018-2023)
Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Pediatrics Medicine Business (2018-2023)
Figure 56. Cipla Revenue Growth Rate in Pediatrics Medicine Business (2018-2023)
Figure 57. Eisai Pharmaceuticals Revenue Growth Rate in Pediatrics Medicine Business (2018-2023)
Figure 58. Eli Lilly Revenue Growth Rate in Pediatrics Medicine Business (2018-2023)
Figure 59. F. Hoffman-La Roche Revenue Growth Rate in Pediatrics Medicine Business (2018-2023)
Figure 60. Glenmark Revenue Growth Rate in Pediatrics Medicine Business (2018-2023)
Figure 61. Helsinn Healthcare Revenue Growth Rate in Pediatrics Medicine Business (2018-2023)
Figure 62. Heron Therapeutics Revenue Growth Rate in Pediatrics Medicine Business (2018-2023)
Figure 63. Ipca Laboratories Revenue Growth Rate in Pediatrics Medicine Business (2018-2023)
Figure 64. Lupin Pharmaceuticals Revenue Growth Rate in Pediatrics Medicine Business (2018-2023)
Figure 65. Merck Sharp & Dohme Revenue Growth Rate in Pediatrics Medicine Business (2018-2023)
Figure 66. RedHill Revenue Growth Rate in Pediatrics Medicine Business (2018-2023)
Figure 67. Sun Pharmaceutical Industries Revenue Growth Rate in Pediatrics Medicine Business (2018-2023)
Figure 68. Takeda Pharmaceutical Revenue Growth Rate in Pediatrics Medicine Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Industry Market Size
